ID P2Y11_HUMAN Reviewed; 374 AA. AC Q96G91; B2R8X9; O43190; Q9BYU4; Q9H170; DT 27-MAY-2002, integrated into UniProtKB/Swiss-Prot. DT 27-MAY-2002, sequence version 2. DT 11-NOV-2015, entry version 131. DE RecName: Full=P2Y purinoceptor 11; DE Short=P2Y11; GN Name=P2RY11; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND TRANS-SPLICING. RC TISSUE=Placenta, and Promyelocyte; RX PubMed=11278528; DOI=10.1074/jbc.M009609200; RA Communi D., Suarez-Huerta N., Dussossoy D., Savi P., Boeynaems J.-M.; RT "Cotranscription and intergenic splicing of human P2Y11 and SSF1 RT genes."; RL J. Biol. Chem. 276:16561-16566(2001). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Placenta; RA King M.M., Aronstam R.S., Sharma S.V.; RT "Isolation of cDNA coding for purinergic receptor P2Y, G protein- RT coupled, 11 (P2RY11)."; RL Submitted (OCT-2003) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 7-374. RC TISSUE=Placenta; RX PubMed=9405388; DOI=10.1074/jbc.272.51.31969; RA Communi D., Govaerts C., Parmentier M., Boeynaems J.-M.; RT "Cloning of a human purinergic P2Y receptor coupled to phospholipase C RT and adenylyl cyclase."; RL J. Biol. Chem. 272:31969-31973(1997). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 162-374. RA Puhl H.L. III, Ikeda S.R., Aronstam R.S.; RT "cDNA clones of human proteins involved in signal transduction RT sequenced by the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Receptor for ATP and ADP coupled to G-proteins that CC activate both phosphatidylinositol-calcium and adenylyl cyclase CC second messenger systems. Not activated by UTP or UDP. CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- TISSUE SPECIFICITY: Highest expression in liver and spleen. CC {ECO:0000269|PubMed:11278528}. CC -!- INDUCTION: Increased by DMSO and retinoic acid. CC -!- MISCELLANEOUS: A chimeric transcript, characterized by the first CC third of PPAN exon 12 joined to P2RY11 exon 2, has been detected. CC It is possibly produced by trans-splicing. The chimeric transcript CC is widely expressed and can be induced by retinoic acid during the CC granulocytic differentiation of the HL-60 cell line. The resulting CC chimeric protein shows a much lower activity than the non-chimeric CC P2RY11 gene product, but qualitatively indistinguishable CC (PubMed:11278528). {ECO:0000305|PubMed:11278528}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC -!- SEQUENCE CAUTION: CC Sequence=AAB88674.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC Sequence=CAC18877.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF030335; AAB88674.1; ALT_INIT; mRNA. DR EMBL; AJ298334; CAC29362.1; -; mRNA. DR EMBL; AJ300588; CAC18877.1; ALT_INIT; mRNA. DR EMBL; AY449733; AAR18077.1; -; mRNA. DR EMBL; AK313550; BAG36326.1; -; mRNA. DR EMBL; CH471106; EAW84077.1; -; Genomic_DNA. DR EMBL; BC073827; AAH73827.1; -; mRNA. DR EMBL; AF498921; AAM18130.1; -; mRNA. DR CCDS; CCDS12226.1; -. DR RefSeq; NP_002557.2; NM_002566.4. DR UniGene; Hs.14468; -. DR PDB; 2B6S; Model; -; A=1-374. DR PDBsum; 2B6S; -. DR ProteinModelPortal; Q96G91; -. DR SMR; Q96G91; 24-324. DR IntAct; Q96G91; 1. DR STRING; 9606.ENSP00000323872; -. DR BindingDB; Q96G91; -. DR ChEMBL; CHEMBL4867; -. DR GuidetoPHARMACOLOGY; 327; -. DR PhosphoSite; Q96G91; -. DR BioMuta; P2RY11; -. DR DMDM; 21263830; -. DR PaxDb; Q96G91; -. DR PRIDE; Q96G91; -. DR DNASU; 5032; -. DR Ensembl; ENST00000321826; ENSP00000323872; ENSG00000244165. DR GeneID; 5032; -. DR KEGG; hsa:5032; -. DR UCSC; uc002mnc.3; human. DR CTD; 5032; -. DR GeneCards; P2RY11; -. DR HGNC; HGNC:8540; P2RY11. DR HPA; HPA014232; -. DR MIM; 602697; gene. DR neXtProt; NX_Q96G91; -. DR Orphanet; 2073; Narcolepsy-cataplexy. DR PharmGKB; PA32869; -. DR eggNOG; ENOG410IW3D; Eukaryota. DR eggNOG; ENOG4111H44; LUCA. DR GeneTree; ENSGT00760000118784; -. DR HOGENOM; HOG000059583; -. DR HOVERGEN; HBG105351; -. DR InParanoid; Q96G91; -. DR KO; K08387; -. DR OrthoDB; EOG71G9TZ; -. DR PhylomeDB; Q96G91; -. DR TreeFam; TF330775; -. DR Reactome; R-HSA-416476; G alpha (q) signalling events. DR Reactome; R-HSA-417957; P2Y receptors. DR Reactome; R-HSA-418555; G alpha (s) signalling events. DR GeneWiki; P2RY11; -. DR GenomeRNAi; 5032; -. DR NextBio; 19388; -. DR PRO; PR:Q96G91; -. DR Proteomes; UP000005640; Chromosome 19. DR Bgee; Q96G91; -. DR Genevisible; Q96G91; HS. DR GO; GO:0005887; C:integral component of plasma membrane; IC:BHF-UCL. DR GO; GO:0005622; C:intracellular; IDA:GOC. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0045031; F:ATP-activated adenosine receptor activity; IDA:BHF-UCL. DR GO; GO:0045028; F:G-protein coupled purinergic nucleotide receptor activity; IEA:InterPro. DR GO; GO:0030594; F:neurotransmitter receptor activity; IDA:BHF-UCL. DR GO; GO:0004872; F:receptor activity; TAS:ProtInc. DR GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc. DR GO; GO:0001973; P:adenosine receptor signaling pathway; IDA:GOC. DR GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IBA:GO_Central. DR GO; GO:0019722; P:calcium-mediated signaling; IDA:BHF-UCL. DR GO; GO:0071318; P:cellular response to ATP; IDA:BHF-UCL. DR GO; GO:0006952; P:defense response; TAS:ProtInc. DR GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:BHF-UCL. DR GO; GO:0023041; P:neuronal signal transduction; IDA:BHF-UCL. DR GO; GO:0007200; P:phospholipase C-activating G-protein coupled receptor signaling pathway; TAS:ProtInc. DR GO; GO:0007268; P:synaptic transmission; IDA:GOC. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR027677; P2Y11_rcpt. DR PANTHER; PTHR24237:SF3; PTHR24237:SF3; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. PE 2: Evidence at transcript level; KW 3D-structure; Cell membrane; Complete proteome; Disulfide bond; KW G-protein coupled receptor; Glycoprotein; Membrane; Polymorphism; KW Receptor; Reference proteome; Transducer; Transmembrane; KW Transmembrane helix. FT CHAIN 1 374 P2Y purinoceptor 11. FT /FTId=PRO_0000070035. FT TOPO_DOM 1 29 Extracellular. {ECO:0000255}. FT TRANSMEM 30 50 Helical; Name=1. {ECO:0000255}. FT TOPO_DOM 51 64 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 65 85 Helical; Name=2. {ECO:0000255}. FT TOPO_DOM 86 116 Extracellular. {ECO:0000255}. FT TRANSMEM 117 137 Helical; Name=3. {ECO:0000255}. FT TOPO_DOM 138 146 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 147 167 Helical; Name=4. {ECO:0000255}. FT TOPO_DOM 168 206 Extracellular. {ECO:0000255}. FT TRANSMEM 207 227 Helical; Name=5. {ECO:0000255}. FT TOPO_DOM 228 245 Cytoplasmic. {ECO:0000255}. FT TRANSMEM 246 266 Helical; Name=6. {ECO:0000255}. FT TOPO_DOM 267 308 Extracellular. {ECO:0000255}. FT TRANSMEM 309 329 Helical; Name=7. {ECO:0000255}. FT TOPO_DOM 330 374 Cytoplasmic. {ECO:0000255}. FT CARBOHYD 4 4 N-linked (GlcNAc...). {ECO:0000255}. FT CARBOHYD 179 179 N-linked (GlcNAc...). {ECO:0000255}. FT DISULFID 102 180 {ECO:0000255|PROSITE-ProRule:PRU00521}. FT VARIANT 87 87 A -> T (in dbSNP:rs3745601). FT /FTId=VAR_020074. SQ SEQUENCE 374 AA; 40345 MW; C02DF9B3B381D25E CRC64; MAANVSGAKS CPANFLAAAD DKLSGFQGDF LWPILVVEFL VAVASNGLAL YRFSIRKQRP WHPAVVFSVQ LAVSDLLCAL TLPPLAAYLY PPKHWRYGEA ACRLERFLFT CNLLGSVIFI TCISLNRYLG IVHPFFARSH LRPKHAWAVS AAGWVLAALL AMPTLSFSHL KRPQQGAGNC SVARPEACIK CLGTADHGLA AYRAYSLVLA GLGCGLPLLL TLAAYGALGR AVLRSPGMTV AEKLRVAALV ASGVALYASS YVPYHIMRVL NVDARRRWST RCPSFADIAQ ATAALELGPY VGYQVMRGLM PLAFCVHPLL YMAAVPSLGC CCRHCPGYRD SWNPEDAKST GQALPLNATA APKPSEPQSR ELSQ //